Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

Clinical trial NCT07215026 · COMPLETED

Trial details

NCT number: NCT07215026
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2025-10-27
Primary completion: 2026-01-21
Enrollment: 833

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.